| enVVeno Medical is a medical device company developing tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease. Co.'s products which it is developing include: the VenoValve®, a porcine based device to be surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous deficiency; and the CoreoGraft®, a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. We show 2 historical shares outstanding datapoints in our coverage of NVNO's shares outstanding history.|
Understanding the changing numbers of NVNO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NVNO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NVNO by allowing them to research NVNO shares outstanding history
as well as any other stock in our coverage universe.